Expiring federal contract
75F40126P00158 — The Univeristy Of Texas M.d. Anderson Cancer Center
Department of Health and Human Services · Food and Drug Administration
- Contract / PIID
- 75F40126P00158
- Incumbent
- The Univeristy Of Texas M.d. Anderson Cancer Center
- Incumbent UEI
- S3GMKS8ELA16
- Current end date
- August 9, 2027
- Potential total value
- $206,192
- Obligated
- $206,192
- NAICS
- 112990 — All Other Animal Production
- PSC
- 8820 — LIVE ANIMALS, NOT RAISED FOR FOOD
- Set-aside
- Not stated
- Start date
- August 5, 2026
- Place of performance
- TX
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
BORDETELLA-FREE BABOON STUDY
Likely rebid window (estimate)
- Sources Sought / RFI: about Aug 2026 – Feb 2027 (6–12 months before the end date)
- RFP: about Apr 2027 – Jun 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 112990)
- 75N98026F00001 — Taconic Biosciences, INC. · ends December 10, 2026 · $1.2M
- 75N95026F00001 — Charles River Laboratories, INC. · ends January 19, 2027 · $1.9M
- 75N93023F00001 — University Of Louisiana At Lafayette · ends March 15, 2027 · $8.5M
- 75N98026F00002 — Envigo Global Services INC · ends July 31, 2027 · $4.6M
- 75N98026F00004 — Envigo Global Services INC · ends July 31, 2027 · $111K
- 75N98026F00011 — Alpha Genesis INC · ends July 31, 2027 · $360K
- 75N98026F00012 — Alpha Genesis INC · ends July 31, 2027 · $140K
- 75N98026F00013 — Alpha Genesis INC · ends July 31, 2027 · $100K
- 75N98026F00014 — Alpha Genesis INC · ends July 31, 2027 · $2.4M
- 75N98026P01283 — Taconic Biosciences, INC. · ends August 9, 2027 · $181K